MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, TGTX made $204,918K in revenue. $19,777K in net income. Net profit margin of 9.65%.

Income Overview

Revenue
$204,918K
Net Income
$19,777K
Net Profit Margin
9.65%
EPS
$0.12
Unit: Thousand (K) dollars
Revenue Breakdown
    • Product
    • License

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Revenue
204,918 162,003* 161,709 141,148
Cost of revenue
33,510 30,168* 28,093 18,938
Stock-based compensation
4,875 2,139* 5,335 4,318
Other research and development
43,521 49,087* 35,543 27,464
Total research and development
48,396 51,225* 40,878 31,782
Stock-based compensation
15,075 11,461* 12,351 12,044
Other selling, general and administrative
73,142 42,138* 51,022 43,541
Total selling, general and administrative
88,217 53,598* 63,373 55,585
Total costs and expenses
170,123 134,990* 132,344 106,305
Operating income
34,795 27,013* 29,365 34,843
Interest expense
7,666 6,571* 6,721 6,716
Loss on extinguishment of debt
-9,153 ---
Other income
2,387 1,706* 3,265 2,793
Total other expense
-14,432 -4,865* -3,456 -3,923
Net income before taxes
20,363 22,147* 25,909 30,920
Income tax expense
586 203,591* -364,986 2,733
Net income
19,777 -181,444 390,895 28,187
Basic EPS
0.14 -1.289 2.69 0.19
Diluted EPS
0.12 -1.129 2.43 0.17
Basic Average Shares
144,439,370 140,793,624 145,416,901 146,739,833
Diluted Average Shares
160,062,326 160,680,857 160,997,977 162,559,404
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Product$201,308K License$3,610K Revenue$204,918K Operating income$34,795K Total costs andexpenses$170,123K Net income beforetaxes$20,363K Total other expense-$14,432K Other income$2,387K Total selling,general and...$88,217K Total research anddevelopment$48,396K Cost of revenue$33,510K Net income$19,777K Income tax expense$586K Loss onextinguishment of debt-$9,153K Interest expense$7,666K Other selling,general and...$73,142K Stock-based compensation$15,075K Other research anddevelopment$43,521K Stock-based compensation$4,875K

TG Therapeutics BRIUMVI Approval Call Slide Deck 12

TG THERAPEUTICS, INC. (TGTX)

TG Therapeutics BRIUMVI Approval Call Slide Deck 12

TG THERAPEUTICS, INC. (TGTX)